News
-
Action Plan on Strengthening the Collaboration in Personalised Medicine between Africa and Europe
The EU-Africa PerMed project has developed an Action Plan to facilitate, foster, and promote collaboration in personalised medicine between Africa and Europe.
-
Podcast Episode 4 released – Proteomics
If DNA is the blueprint, proteins are the builders, communicators and catalyzers. They’re the ones actually getting stuff done in your cells. Welcome to the world of proteomics – the study of all the proteins your body makes. Think of proteins as the building blocks and dynamic forces that make life possible, each one with…
-
WHO releases new principles for ethical human genomic data collection and sharing
The World Health Organization (WHO) has issued a set of principles for the ethical collection, access, use and sharing of human genomic data.
EP PerMed JTC 2025
#PGxPM2025
With its second Joint Transnational Call (JTC), EP PerMed aims to fund human health research on pharmacogenomic strategies for personalised medicine approaches. The full call text is expected to be published in mid-December 2024. The deadline for submission of pre-proposals is 18 February 2025. Funding decisions are expected to be communicated in October 2025.
Mission & Objectives
The vision of the European Partnership for Personalised Medicine is to improve health outcomes within sustainable healthcare systems through research, development, innovation and implementation of personalised medicine approaches for the benefit of patients, citizens, and society.
Dr. Wolfgang Ballensiefen, Coordinator
Governance & Boards
The European Partnership for Personalised Medicine gathers together more than 50 partners from over 20 countries. The Consortium is managed by a so-called Coordination Unit (CU) and General Assembly (GeA). The day-to-day business, planning and implementation of activities is realized through five Work Packages. The EP PerMed overarching Advisory Bodies are ICPerMed, an Advisory Board and a Stakeholder Forum.